What is the appropriate systemic chemotherapy for lymphocyte-predominant Hodgkin's lymphoma?
Canellos
George P
GP
Mauch
Peter
P
D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008214:Lymphocytes / Q000473:pathology*
D018906:Antineoplastic Agents, Alkylating